• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by SI-BONE Inc.

    5/7/25 4:21:02 PM ET
    $SIBN
    Medical/Dental Instruments
    Health Care
    Get the next $SIBN alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001218802
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    SI-BONE, Inc.
    SEC File Number
    001-38701
    Address of Issuer
    471 El Camino Real, Suite 101
    Santa Clara
    CALIFORNIA
    95050
    Phone
    4082070700
    Name of Person for Whose Account the Securities are To Be Sold
    DAVID & LAURA FRANCIS JOINT REV TRU/A DTD 01/03/2003
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Officer

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common
    Morgan Stanley Smith Barney LLC Executive Financial Services
    1 New York Plaza
    8th Floor
    New York � NY � 10004
    38504633390.804261451405/07/2025
    NASDAQ


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common01/01/2025Restricted Stock UnitsIssuerCheckbox not checked730301/01/2025N/A
    Common02/15/2025Performance Stock UnitsIssuerCheckbox not checked3120102/15/2025N/A

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    DAVID & LAURA FRANCIS JOINT REV TRU/A DTD 01/03/2003
    471 El Camino Real, Suite 101
    Santa Clara � CA � 95050
    Common02/18/202546233795914.58

    144: Remarks and Signature

    Remarks
    The securities to be sold were acquired upon the vesting of restricted stock units during the period of 1/15/25 through 2/15/25
    Date of Notice
    05/07/2025
    Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1
    12/13/2024

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/ Laura Francis

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $SIBN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SIBN

    DatePrice TargetRatingAnalyst
    8/6/2024$27.00 → $19.00Buy
    Needham
    3/28/2024$25.00Overweight
    Piper Sandler
    10/12/2022$20.00Buy
    Jefferies
    4/7/2022$34.00Overweight
    Cantor Fitzgerald
    3/1/2022$30.00 → $28.00Overweight
    Morgan Stanley
    1/18/2022$43.00 → $36.00Buy
    B of A Securities
    12/21/2021$35.00 → $30.00Buy
    Truist Securities
    11/9/2021$42.00 → $36.00Market Outperform
    JMP Securities
    More analyst ratings

    $SIBN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025

      SANTA CLARA, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 BofA Securities Healthcare Conference in Las Vegas. Management will be hosting a fireside chat on Tuesday, May 13, 2025, at 8:40 a.m. Pacific Time/11:40 a.m. Eastern Time. Investors interested in listening to the conference call may do so by registering at this link: https://bofa.veracast.com/webcasts/bofa/healthcare2025/id92Nrrn.cfm. Live audio of the webcast will be available on the "Investors" section of the company's website at: www.si-bone.com. The webcast wil

      5/6/25 4:09:00 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance

      First Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $47.3 million, representing growth of 24.9%U.S. revenue of $44.8 million, representing growth of 26.6%Gross margin of 79.7%, representing an improvement of 80 basis pointsNet loss of $6.5 million, representing an improvement of 40.0%Positive adjusted EBITDA of $0.5 million$144.4 million in cash and equivalents, with net cash usage in the quarter declining 31.7% to $5.6 million Recent Operational Highlights (any comparisons are to the prior year period) Over 1,400 active U.S. physicians with 300 physicians

      5/5/25 4:09:00 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SI-BONE To Report First Quarter 2025 Financial Results on May 5, 2025

      SANTA CLARA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the first quarter of 2025 after market close on Monday, May 5, 2025. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by registering at this link: https://edge.media-server.com/mmc/p/ueassh6s. Live audio of the webcast will be available on the "Investors" section of the company's website at: www.si-bone.com. The webcast will be archived and available for replay for a

      4/14/25 4:09:00 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care

    $SIBN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Francis Laura sold $661,368 worth of shares (38,504 units at $17.18) (SEC Form 4)

      4 - SI-BONE, Inc. (0001459839) (Issuer)

      5/9/25 7:01:42 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • Chief Financial Officer Maheshwari Anshul sold $599,033 worth of shares (33,287 units at $18.00), decreasing direct ownership by 12% to 237,006 units (SEC Form 4)

      4 - SI-BONE, Inc. (0001459839) (Issuer)

      5/9/25 7:00:36 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • Director Dunn Jeffrey W sold $4,628 worth of shares (336 units at $13.78), decreasing direct ownership by 3% to 12,536 units (SEC Form 4)

      4 - SI-BONE, Inc. (0001459839) (Issuer)

      5/2/25 5:08:52 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care

    $SIBN
    SEC Filings

    See more
    • SEC Form 144 filed by SI-BONE Inc.

      144 - SI-BONE, Inc. (0001459839) (Subject)

      5/7/25 4:21:02 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SEC Form 10-Q filed by SI-BONE Inc.

      10-Q - SI-BONE, Inc. (0001459839) (Filer)

      5/6/25 4:05:51 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SI-BONE Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - SI-BONE, Inc. (0001459839) (Filer)

      5/5/25 4:12:45 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care

    $SIBN
    Financials

    Live finance-specific insights

    See more
    • SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025

      SANTA CLARA, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 BofA Securities Healthcare Conference in Las Vegas. Management will be hosting a fireside chat on Tuesday, May 13, 2025, at 8:40 a.m. Pacific Time/11:40 a.m. Eastern Time. Investors interested in listening to the conference call may do so by registering at this link: https://bofa.veracast.com/webcasts/bofa/healthcare2025/id92Nrrn.cfm. Live audio of the webcast will be available on the "Investors" section of the company's website at: www.si-bone.com. The webcast wil

      5/6/25 4:09:00 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance

      First Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $47.3 million, representing growth of 24.9%U.S. revenue of $44.8 million, representing growth of 26.6%Gross margin of 79.7%, representing an improvement of 80 basis pointsNet loss of $6.5 million, representing an improvement of 40.0%Positive adjusted EBITDA of $0.5 million$144.4 million in cash and equivalents, with net cash usage in the quarter declining 31.7% to $5.6 million Recent Operational Highlights (any comparisons are to the prior year period) Over 1,400 active U.S. physicians with 300 physicians

      5/5/25 4:09:00 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SI-BONE To Report First Quarter 2025 Financial Results on May 5, 2025

      SANTA CLARA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the first quarter of 2025 after market close on Monday, May 5, 2025. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by registering at this link: https://edge.media-server.com/mmc/p/ueassh6s. Live audio of the webcast will be available on the "Investors" section of the company's website at: www.si-bone.com. The webcast will be archived and available for replay for a

      4/14/25 4:09:00 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care

    $SIBN
    Leadership Updates

    Live Leadership Updates

    See more
    • Bruker Appoints Laura Francis to its Board of Directors

      Bruker Corporation (NASDAQ:BRKR) today announced that its Board of Directors has appointed Laura Francis to serve on its board as an independent director, effective as of February 18, 2025. Ms. Francis is also expected to join Bruker's Audit Committee as a financial expert after Bruker's annual shareholder meeting at the end of May 2025. Laura Francis is the Chief Executive Officer and a Board Member of SI-BONE, Inc. (NASDAQ:SIBN), a medical device company solving musculoskeletal disorders of the sacropelvic anatomy. She was previously the Chief Financial Officer and Chief Operating Officer of the company. Prior to joining SI-BONE, Ms. Francis held other executive and leadership roles with

      2/21/25 8:00:00 AM ET
      $BRKR
      $PGNY
      $SIBN
      $SWAV
      Biotechnology: Laboratory Analytical Instruments
      Industrials
      Misc Health and Biotechnology Services
      Health Care
    • Mainstay Medical Announces Appointment of Jeffrey Dunn and Eric Major to its Board of Directors

      Mainstay Medical Holdings plc today announced the appointment of two new independent members to the company's board of directors, Jeffrey Dunn and Eric Major. These appointments bring Mainstay's total board membership to seven. "We are pleased to welcome these two transformational business leaders as new independent directors on the Board," said David Brabazon, Chairman of the Mainstay Board of Directors. "Their deep experience will be invaluable to Mainstay as we grow our business and pursue our mission to serve patients with intractable chronic low back pain." "As our business evolves and we continue to focus on commercial growth, broadening the industry expertise on our Board will help

      12/14/21 8:00:00 AM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SI-BONE Appoints Anshul Maheshwari as Chief Financial Officer and Announces the Addition of Helen Loh and Laura Francis to the Board of Directors

      SANTA CLARA, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (NASDAQ:SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced the appointment of Anshul Maheshwari as the company's Chief Financial Officer effective April 20, 2021, and the addition of Helen Loh and Laura Francis to its Board of Directors effective April 18, 2021. The appointment of Mr. Maheshwari completes the recently announced senior leadership transition which includes Laura Francis succeeding Jeff Dunn as Chief Executive Officer, and Tony Recupero becoming President, Commercial Operations. Jeff Dunn will remain with the compa

      4/19/21 7:00:49 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care

    $SIBN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Needham reiterated coverage on SI-BONE with a new price target

      Needham reiterated coverage of SI-BONE with a rating of Buy and set a new price target of $19.00 from $27.00 previously

      8/6/24 8:40:50 AM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • Piper Sandler initiated coverage on SI-BONE with a new price target

      Piper Sandler initiated coverage of SI-BONE with a rating of Overweight and set a new price target of $25.00

      3/28/24 7:47:33 AM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • Jefferies initiated coverage on SI-BONE with a new price target

      Jefferies initiated coverage of SI-BONE with a rating of Buy and set a new price target of $20.00

      10/12/22 9:04:16 AM ET
      $SIBN
      Medical/Dental Instruments
      Health Care

    $SIBN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by SI-BONE Inc.

      SC 13G/A - SI-BONE, Inc. (0001459839) (Subject)

      11/14/24 6:27:27 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by SI-BONE Inc.

      SC 13G - SI-BONE, Inc. (0001459839) (Subject)

      11/14/24 4:43:38 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by SI-BONE Inc.

      SC 13G - SI-BONE, Inc. (0001459839) (Subject)

      11/8/24 12:14:44 PM ET
      $SIBN
      Medical/Dental Instruments
      Health Care